Neurogene
NGNE
82 hedge funds and large institutions have $342M invested in Neurogene in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 23 increasing their positions, 33 reducing their positions, and 8 closing their positions.
0.02% less ownership
Funds ownership: 3.3% → 3.28% (-0.02%)
2% less funds holding
Funds holding: 84 → 82 (-2)
13% less capital invested
Capital invested by funds: $391M → $342M (-$48.9M)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
30% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 33
63% less call options, than puts
Call options by funds: $1M | Put options by funds: $2.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$5.13M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.66M |
| 3 |
Goldman Sachs
New York
|
+$3.96M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.44M |
| 5 |
Citigroup
New York
|
+$1.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.92M |
| 2 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$2.66M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$2.06M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$2.03M |
| 5 |
Two Sigma Investments
New York
|
-$1.97M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Macquarie Group
Sydney, NSW 2000,
Australia
| $6K | -$3.07K | -12 | -32% |
|
|
GWM
77
Geneos Wealth Management
Englewood,
Colorado
| $2K | – | – | – |
|
78
Simplex Trading
Chicago,
Illinois
| $1K | -$6.39K | -25 | -83% |
|
79
Daiwa Securities Group
Tokyo,
Japan
| $1K | – | – | – |
|
80
Group One Trading
Chicago,
Illinois
| $1K | +$1.28K | +5 | New |
|
|
AIG
81
American International Group
New York
| $231 | +$767 | +3 | +0.3% |
|
|
82
CIBC Private Wealth Group
Atlanta,
Georgia
| – | -$2.66M | -9,421 | Closed |
|
83
AQR Capital Management
Greenwich,
Connecticut
| – | -$335K | -1,188 | Closed |
|
84
D.E. Shaw & Co
New York
| – | -$242K | -857 | Closed |
|
85
Squarepoint
New York
| – | -$237K | -839 | Closed |
|
86
UBS AM
Chicago,
Illinois
| – | -$210K | -745 | Closed |
|
|
MAM
87
Martingale Asset Management
Boston,
Massachusetts
| – | -$195K | -691 | Closed |
|
|
TI
88
Trexquant Investment
Stamford,
Connecticut
| – | -$171K | -607 | Closed |
|
|
PFO
89
Pathstone Family Office
Englewood,
New Jersey
| – | -$28K | -100 | Closed |
|
|
CS
90
Candriam SCA
Strassen, Luxembourg,
Luxembourg
| – | +$511 | +2 | New |
|
NGNE Hedge Fund Activity: Q1 2021 in Review
82 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q1 2021, worth a combined $342M — down 13% from $391M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of NGNE and 6 opened new positions — a net loss of 2 holders — while 33 trimmed existing stakes and 23 added.
The largest buyer was State Street, adding an estimated $5.13M. The largest seller was Dimensional Fund Advisors, cutting an estimated $2.92M.
- 82 institutional investors held Neurogene (NGNE) as of Q1 2021, down from 84 in Q4 2020.
- Funds reported $342M of Neurogene stock for Q1 2021, down 13% quarter-over-quarter.
- 6 funds opened new Neurogene positions in Q1 2021 and 8 closed out, a net change of -2 holders.
- The largest Neurogene buyer in Q1 2021 was State Street, an estimated $5.13M added.
- The largest Neurogene seller in Q1 2021 was Dimensional Fund Advisors, an estimated $2.92M sold.
Based on aggregated 13F filings for Q1 2021.